IBS Treatment Industry 2019
Description:-
Irritable bowel syndrome (IBS) is one of the major disorders affecting the digestive system of humans. Diarrhea, bloating, stomach cramps, and constipation, are some of the symptoms of the disorder. In spite of the fact that the reason for IBS is obscure, however, few factors that cause IBS are extreme disease, inflammation of the digestion tracts, contraction of muscles in the intestine, changes in gut bacteria, and nerve disorders. The rising pervasiveness of gastrointestinal infections and confusion, the geriatric populace, undesirable eating regimen, uneasiness, depression, and changing way of life in the Americas are the key drivers of the Americas IBS market. The Americas IBS treatment market is projected to grow at a CAGR of 9.3% during the forecast period 2017-2023.
Get a Sample Report@ https://www.wiseguyreports.com/sample-request/3711008-ibs-treatment-market-information-by-types-ibs-d
For more information or any query mail at sales@wiseguyreports.com
Moreover, expanding consumer awareness about the IBS syndrome has increased the footfall of patient in the hospitals and other healthcare centers. Moreover, expanding expenditure in the medicinal services area is fueling the development of the IBS treatment market. However, strict FDA controls and inadmissible adequacy of the treatment may harm the development of the Americas IBS treatment market amid the forecast period (2017-2023).
Market Segmentation
The Americas IBS treatment market is segmented on the basis of its drugs type, types, end user and regional analysis. Based on its drugs type, the Americas IBS treatment market is sectioned into linaclotide, lubiprostone, eluxadoline, alosetron, rifaximin, and others. On the basis its types, the market is classified into IBS-C, IBS-D, IBS-M. Based on its end users, it is divided into clinics, research laboratories, and hospitals.
Regional Analysis
Geographically, the Americas IBS treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
The list of key players in Americas IBS treatment market include companies like Allergan Plc (Ireland), Ironwood Pharmaceuticals, Inc. (U.S.), Sucampo Pharmaceuticals (U.S.), Astellas Pharma Inc. (Japan), Abbott Laboratories (U.S.), Valeant Pharmaceuticals (Canada), Synergy Pharmaceuticals, Inc. (U.S.), Nestle (Switzerland), Ardelyx, Inc. (U.S.), Sebela Pharmaceuticals (Ireland), Alfasigma USA, Inc. (Italy), Probi (Sweden), RedHill Biopharma Ltd. (Israel), Ipsen (France), AstraZeneca (U.K), Novartis AG (Switzerland), Synthetic Biologics, Inc. (U.S.), Takeda Pharmaceutical Company Ltd (Japan), Protagonist Therapeutics Inc. (U.S.), Lexicon Pharmaceuticals, Inc. (U.S.), Pfizer Inc (U.S.), 4D pharma plc (U.K), Innovate Biopharmaceuticals (U.S.), among others.
Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3711008-ibs-treatment-market-information-by-types-ibs-d
Table Of Contents – Major Key Points
1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Data points received from the doctors/ gastrologist:
3.1.3 Data points received from the manufacturer/ pharmaceutical companies:
3.1.4 Data points received from Hospitals, Clinics:
3.1.5 Secondary Research Methodology
3.1.6 Market Share Analysis
3.1.7 Trade Analysis
3.1.8 Market Pricing Approach
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of anxiety (Impact Weightage: 37%)
4.2.2 Strong clinical pipeline (Impact Weightage: 35%)
4.2.3 Increasing prevalence of depression (Impact Weightage: 28%)
4.3 Restraints
4.3.1 Strict FDA regulations (Impact Weightage: 60%)
4.3.2 Unsatisfactory effectiveness of the treatment (Impact Weightage: 40%)
4.4 Opportunity
4.5 Mega Trends
4.6 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Research and Development
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-sales Monitoring
5.2 Porters Five Forces
5.2.1 Threat of New Entrants (Medium to High)
5.2.2 Bargaining power of suppliers (Medium)
5.2.3 Threat of Substitutes (Medium to High)
5.2.4 Bargaining Power of Buyers (Medium)
5.2.5 Intensity of Rivalry (Medium to High)
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
Continued……
Buy 1-user PDF @https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3711008
ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com